Literature DB >> 6348542

Thymic hormone therapy for histiocytosis X?

E G Davies, R J Levinsky, M Butler, V Broadbent, J Pritchard, J Chessells.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6348542

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Suppressor-cell dysfunction in children with histiocytosis-X.

Authors:  B T Shannon; W A Newton
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

2.  Circulating thymic hormone activity in young cancer patients.

Authors:  R Consolini; B Cei; P Cini; E Bottone; L Casarosa
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

3.  Histiocytosis X--current controversies.

Authors:  V Broadbent; J Pritchard
Journal:  Arch Dis Child       Date:  1985-07       Impact factor: 3.791

Review 4.  Histiocytoses.

Authors:  J L Stéphan
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

5.  Langerhans cell histiocytosis--clinical and epidemiological aspects.

Authors:  V Broadbent; R M Egeler; M E Nesbit
Journal:  Br J Cancer Suppl       Date:  1994-09

6.  Langerhans cell histiocytosis--a 31 year review.

Authors:  P Leavey; M Varughese; F Breatnach; A O'Meara
Journal:  Ir J Med Sci       Date:  1991-09       Impact factor: 1.568

7.  Histiocytosis X: an ophthalmological review.

Authors:  A T Moore; J Pritchard; D S Taylor
Journal:  Br J Ophthalmol       Date:  1985-01       Impact factor: 4.638

Review 8.  Treatment of Langerhans cell histiocytosis--evolution and current approaches.

Authors:  S Ladisch; H Gadner
Journal:  Br J Cancer Suppl       Date:  1994-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.